Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,202,860 | 479,728 | 1,862,300 | 1,405,035 | 917,419 |
| Depreciation Amortization | 355,102 | 190,963 | 531,700 | 373,357 | 225,880 |
| Income taxes - deferred | -146,506 | -79,558 | -245,100 | -166,187 | -118,047 |
| Accounts receivable | -188,961 | -197,685 | -126,700 | -219,860 | -185,688 |
| Other Working Capital | -335,880 | -461,371 | 87,500 | -204,406 | -245,993 |
| Other Operating Activity | 208,604 | 172,549 | 235,400 | 288,134 | 210,580 |
| Operating Cash Flow | $1,095,219 | $104,626 | $2,345,100 | $1,476,073 | $804,151 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -118,308 | -54,306 | -246,300 | -167,628 | -87,440 |
| Net Acquisitions | -25,000 | -25,000 | -15,000 | N/A | N/A |
| Purchase Of Investment | -1,787,606 | -666,211 | -3,278,100 | -2,473,609 | -1,617,974 |
| Sale Of Investment | 1,317,525 | 757,512 | 5,190,100 | 5,025,218 | 4,404,707 |
| Purchase Sale Intangibles | N/A | N/A | -3,262,700 | -3,262,719 | -3,262,719 |
| Other Investing Activity | -10,745 | -6,002 | -3,255,400 | -3,278,673 | -3,269,593 |
| Investing Cash Flow | $-624,134 | $5,993 | $-1,604,700 | $-894,692 | $-570,300 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 22,363 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | -452,400 | -452,340 | -452,340 |
| Common Stock Issued | 33,477 | N/A | 66,800 | 56,367 | 39,002 |
| Common Stock Repurchased | -336,905 | N/A | -400,300 | -400,308 | -41,023 |
| Other Financing Activity | 95,943 | 92,512 | 69,400 | 68,572 | 45,174 |
| Financing Cash Flow | $-207,485 | $114,875 | $-716,500 | $-727,709 | $-409,187 |
| Exchange Rate Effect | -2,965 | 545 | 8,000 | 3,418 | -2,878 |
| Beginning Cash Position | 602,562 | 602,562 | 570,700 | 570,721 | 570,721 |
| End Cash Position | 863,197 | 828,601 | 602,600 | 427,811 | 392,507 |
| Net Cash Flow | $260,635 | $226,039 | $31,900 | $-142,910 | $-178,214 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,095,219 | 104,626 | 2,345,100 | 1,476,073 | 804,151 |
| Capital Expenditure | -118,308 | -54,306 | -246,300 | -167,628 | -87,440 |
| Free Cash Flow | 976,911 | 50,320 | 2,098,800 | 1,308,445 | 716,711 |